Protein Age Bias in Target Degradation by PROTACs
Abstract:
Targeted protein degradation (TPD) by PROteolysis TArgeting Chimeras (PROTACs) has emerged as a powerful chemical biology and therapeutic modality, yet many degraders exhibit incomplete target clearance and characteristic rebound kinetics despite continuous exposure. The mechanistic basis for this behavior remains poorly understood. Here we uncover protein age as a previously unrecognized determinant of PROTAC efficacy. Using CG □SLENP, a chemical genetics strategy that selectively labels newly synthesized and pre □existing proteins within the same living cell, we directly resolve PROTAC□induced degradation of distinct intracellular protein populations. Applying this approach to the bromodomain protein BRD4, we show that two mechanistically and structurally distinct PROTACs, dBET6 and MZ□1, preferentially degrade pre □existing BRD4, while newly synthesized BRD4 is degraded substantially more slowly and incompletely. This age□dependent degradation bias is observed in live□cell imaging, across compound concentrations and time scales, and for both reporter and endogenous BRD4. These findings reveal that PROTAC□mediated degradation is governed not only by target engagement and ternary complex formation, but also by the dynamic balance between protein synthesis and degradation. By identifying temporal proteostasis as a critical parameter in TPD, this work provides a mechanistic framework for incomplete degradation and rebound kinetics and establishes protein maturation state as an important consideration for degrader design and evaluation.
Insights
Protein age significantly impacts targeted protein degradation (TPD) using PROteolysis TArgeting Chimeras (PROTACs). Newly synthesized proteins are degraded less efficiently than pre-existing ones, explaining incomplete target clearance.
Area of Science:
- Chemical Biology
- Molecular Biology
- Drug Discovery
Background:
- Targeted protein degradation (TPD) via PROteolysis TArgeting Chimeras (PROTACs) is a promising therapeutic strategy.
- Incomplete target clearance and rebound kinetics are common limitations of current PROTACs.
- The underlying mechanisms for these limitations are not fully understood.
Purpose of the Study:
- To investigate the role of protein age in PROTAC efficacy.
- To elucidate the mechanistic basis for incomplete target degradation and rebound kinetics.
- To identify new parameters for optimizing PROTAC design.
Main Methods:
- Utilized CG □SLENP, a chemical genetics strategy, to differentiate and label newly synthesized and pre-existing proteins within single cells.
- Applied this method to study the degradation of the bromodomain protein BRD4 using two distinct PROTACs (dBET6 and MZ□1).
- Performed live-cell imaging and quantitative analysis across various compound concentrations and time scales.
Main Results:
- PROTACs preferentially degraded pre-existing BRD4 over newly synthesized BRD4.
- Newly synthesized BRD4 exhibited slower and incomplete degradation kinetics.
- This age-dependent degradation bias was consistent across different PROTACs, concentrations, and time points.
Conclusions:
- Protein age is a critical, previously unrecognized determinant of PROTAC efficacy.
- PROTAC-mediated degradation is influenced by the balance between protein synthesis and degradation (proteostasis).
- Understanding protein maturation state is essential for designing effective PROTACs and overcoming limitations like incomplete degradation.
More Related Videos
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
08:52Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
Published on: April 6, 2022
Related Concept Videos
01:13The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...